APLS vs AAPL: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Apple Inc in 2026
APLS
Apellis Pharmaceuticals Inc
$40.88
AAPL
Apple Inc
$258.74
Key Metrics Comparison
| Metric | APLS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $5.22B | N/A | APLS |
| P/E Ratio | 226.94 | 32.80 | AAPL |
| EPS (TTM) | $0.18 | $7.89 | AAPL |
| Revenue Growth | -0.1% | 0.2% | AAPL |
| Gross Margin | 60.3% | 47.3% | APLS |
Analyze APLS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or AAPL a better investment?
Comparing APLS and AAPL: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and AAPL?
APLS (Apellis Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or AAPL?
Based on P/E ratios, AAPL trades at a lower multiple (32.8x vs 226.9x).
Which is growing faster: APLS or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.1% for APLS.
Which company is more profitable: APLS or AAPL?
Apellis Pharmaceuticals Inc (APLS) has higher gross margins at 60.3% compared to 47.3% for AAPL.
Which is the larger company: APLS or AAPL?
Apellis Pharmaceuticals Inc (APLS) is larger with a market cap of $5.22B compared to N/A for AAPL.
Should I buy APLS or AAPL in 2026?
Both APLS and AAPL have investment merit. APLS trades at $40.88 while AAPL trades at $258.74. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and AAPL stock?
Key differences: Market Cap ($5.22B vs N/A), P/E Ratio (226.9x vs 32.8x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (60.3% vs 47.3%).